SlideShare a Scribd company logo
Anticholinergic
Drugs
INTRODUCTION
• Anticholinergic drugs are agents which block the effects
of acetylcholine on cholinergic receptors but
conventionally antimuscarinic drugs are referred to as
anticholinergic drugs.
• They are also called cholinergic blocking or
parasympatholytic drugs.
• Drugs that block the nicotinic receptors are ganglion
blockers and neuromuscular blockers.
• Anticholinergic drugs include atropine and related
drugs—atropine is the prototype.
• Atropine is obtained from the plant Atropa
belladonna. Atropine and scopolamine (hyoscine) are
the belladonna alkaloids.
• They compete with acetylcholine for muscarinic
receptors and block these receptors—they are
muscarinic antagonists.
CLASSIFICATION
Natural
alkaloids
Semisynthetic
derivatives
Synthetic
substitutes
Atropine, hyoscine
(scopolamine
Homatropine,
ipratropium bromide
Mydriatics(Eucatropine)
Antispasmodic-antisecretory
agentsPropantheline,
Antiparkinsonian agents
Benzhexol
Actions of anticholinergic drug
• The actions of atropine and scopolamine are similar
except that atropine is a CNS stimulant while
scopolamine is a CNS depressant and causes
sedation.
1. CVS—Atropine increases heart rate. In large doses,
vasodilation and hypotension occurs.
Actions of anticholinergic drug
2. Secretions—Atropine reduces all secretions except
milk. Lacrimal, salivary, nasopharyngeal,
tracheobronchial and gastric secretions are
decreased.
• Decreased salivation results in dry mouth and
difficulty in swallowing—it is an antisialogogue.
Sweating is also reduced
Actions of anticholinergic drug
3. Smooth muscle
• GIT – ↓ tone and motility and relieves spasm →may
result in constipation.
• Biliary tract – smooth muscles are relaxed; biliary
spasm is relieved.
• Bronchi – atropine causes bronchodilatation.
• Urinary bladder – relaxes ureter and urinary bladder
and may cause urinary retention particularly in the
elderly men because they may be having prostatic
hypertrophy.
Actions of anticholinergic drug
4. Eye—On local instillation, atropine produces
mydriasis by blocking the muscarinic receptors in the
sphincter pupillae.
• The ciliary muscle is paralysed resulting in cycloplegia
or paralysis of accommodation.
• Because of mydriasis, the iris may block the drainage
of aqueous humor—IOP increases and may
precipitate glaucoma in some patients.
Actions of anticholinergic drug
5. CNS—In higher doses atropine stimulates the CNS
resulting in restlessness, disorientation,
hallucinations and delirium. In contrast, scopolamine
produces sedation and drowsiness.
Pharmacokinetics
• Atropine and hyoscine are well-absorbed,
cross the BBB and are metabolised in the liver.
Adverse effects
Use of anticholinergic agents may result to these adverse
effects:
• CNS: blurred vision, pupil dilation, photophobia,
cycloplegia, increased intraocular pressure, weakness,
dizziness, insomnia
• CV: tachycardia, palpitation
• GI: dry mouth, altered taste perception, nausea,
heartburn, constipation
• GU: urinary hesitancy and retention, heat prostration
Uses of Belladonna Alkaloids
1. As antispasmodic
• In diarrhoea and dysentery, atropine relieves colic
and abdominal pain.
• In renal and biliary colic—atropine is used with
morphine because atropine partly overcomes spasm
of the sphincter of Oddi.
• Nocturnal enuresis in children and in paraplegia
atropine reduces urinary frequency.
Use
2. As mydriatric and cycloplegic
• Diagnostic for testing error of refraction and
fundoscopic examination of the eye.
• Therapeutic To provide rest to the iris in iritis,
iridocyclitis, keratitis and after partial iridectomy.
• Mydriatics are used alternately with miotics to break
adhesions between the iris and the lens - both for
the treatment and prevention of adhesion formation.
Use
3. As pre-anaesthetic medication When administered
30 min before anaesthesia, atropine reduces salivary
and respiratory secretions. This will prevent the
development of laryngospasm. It also prevents
bradycardia during surgery. Its bronchodilator action
is of additional value.
• Glycopyrrolate an atropine substitute, is most
commonly used for this purpose
Use
4. In organophosphorus poisoning Atropine is life saving
in OP poisoning and is also useful in mushroom
poisoning.
5. In bronchial asthma, peptic ulcer and parkinsonism
Atropine derivatives are preferred over atropine
Use
6. Motion sickness Hyoscine given 30 minutes before
the journey prevents travelling sickness. Transdermal
hyoscine patches are available to be applied behind
the ear for a prolonged action
7. Hyoscine can also be used during labour to produce
sedation and amnesia.
Drug interactions
• When anticholinergics are given with other drugs
that also have anticholinergic property like
antihistaminics, phenothiazines, tricyclic
antidepressants
ATROPINE SUBSTITUTES
• Belladonna alkaloids produce a wide range of effects,
most of which are of therapeutic value.
• But these can also result in various side effects since
they lack selectivity.
• Hence several semisynthetic and synthetic
derivatives have been introduced some of which
have selective actions
• Mydriasis and cycloplegia produced by atropine last
for 7–10 days. The derivatives have shorter action
(6–24 hrs), tropicamide being the shortest acting.
• Some can selectively produce either prominent
mydriasis or cycloplegia.
• Antispasmodics or spasmolytics are used to relieve
spasms of the gastrointestinal tract, biliary tract,
ureter and uterus. They are also found to be useful in
irritable bowel syndrome. Some of them in addition,
reduce gastrointestinal motility.
Atropine substitutes
Indications Derivatives
1. On the eye – mydriatics
and cycloplegics
Homatropine, eucatropine, cyclopentolate,
tropicamide
2. As antispasmodics Propantheline, methantheline, dicyclomine,
flavoxate hydrochloride, oxybutynin
chloride, oxyphenonium, glycopyrrolate,
clidinium
3. Peptic Ulcer Pirenzepine, telenzepine
4. Bronchial asthma Ipratropium, tiotropium
5. Preanaesthetic
medication
Glycopyrrolate
6. Urinary disorders Oxybutynin, tolterodine, propiverine,
dicyclomine
7. Antiparkinsonian drugs Benzhexol, benztropine, trihexyphenidyl.
• Pirenzepine and telenzepine are selective M1 blockers which
inhibit gastric secretion at doses that do not affect other
functions.
• Pirenzepine also does not cross the BBB – hence has no CNS
effects. They are tried in peptic ulcer.
• When used in bronchial asthma, atropine thickens the
bronchial secretions and interferes with the movement of
cilia, thus favouring formation of mucus plugs.
• Ipratropium bromide is a bronchodilator that does
not affect mucociliary activity.
• When given as inhalation it acts only on the airways
and does not produce any significant systemic effects
because it is poorly absorbed.
• Glycopyrrolat is an antisialogogue (reduces salivary
secretions). It is e a quaternary amine – does not cross the
BBB – therefore no effects on the CNS. It is given IM as
preanaesthetic medication and in dental practice when it is
necessary to reduce salivary secretions.
• Benztropine, benzhexol and trihexyphenidyl are the
derivatives used in drug induced parkinsonism.
• Urinary disorders – atropine substitutes are used to
reduce urinary urgency and frequency to relieve
bladder spasm and improve bladder capacity in
urinary disorders and following urologic surgeries.
They are also tried in nocturnal enuresis in children.
Contraindications and Cautions
The following are contraindications and cautions for the use
of anticholinergics:
• Allergy to any component of the drug. To prevent
hypersensitivity reaction
• Glaucoma. Can be exacerbated by blockade of PNS.
• Intestinal atony, paralytic ileus, GI obstruction. Can be
exacerbated with further slowing of GI activity.
• Pregnancy. Potential adverse effects on the fetus.
Nursing Considerations
Here are important nursing considerations when administering
anticholinergics:
Nursing Assessment
These are the important things the nurse should include in
conducting assessment, history taking, and examination:
• Assess for contraindications or cautions (e.g., history
of allergy to drug, GI obstruction, hepatorenal dysfunction,
etc.) to avoid adverse effects.
• Establish baseline physical assessment to monitor for any
potential adverse effects.
• Assess neurological status (e.g., orientation, affect, reflexes)
to evaluate any CNS effects.
• Assess abdomen (e.g., bowel sounds, bowel
and bladder patterns, urinary output) to evaluate for GI and
GU adverse effects.
• Monitor laboratory test results to determine need for possible
dose adjustments and to identify potential toxicity.
• Ensure proper administration of the drug to ensure effective
use and decrease the risk of adverse effects.
• Monitor patient response (e.g., blood pressure, ECG, urine
output) for changes that may indicate need to adjust dose.
• Provide comfort measures (e.g., sugarless lozenges, lighting
control, small and frequent meals) to help patient cope with
drug effects.
• Provide patient education about drug effects and warning
signs to report to enhance knowledge about drug therapy and
promote compliance.
Anticholinergic drugs_abhijit.pptx

More Related Content

What's hot

Antiadrenergic system and drugs
Antiadrenergic system and drugsAntiadrenergic system and drugs
Antiadrenergic system and drugs
BikashAdhikari26
 
CNS stimulants - Parmacology
CNS stimulants - ParmacologyCNS stimulants - Parmacology
CNS stimulants - Parmacology
Areej Abu Hanieh
 
Skeletal muscle relaxants
Skeletal muscle relaxantsSkeletal muscle relaxants
Skeletal muscle relaxants
BikashAdhikari26
 
Antiepileptics
AntiepilepticsAntiepileptics
Antiepileptics
Kalaivanisathishr
 
Anticholinergic drugs
Anticholinergic drugsAnticholinergic drugs
Anticholinergic drugs
Naser Tadvi
 
Sedatives & hypnotics
Sedatives & hypnoticsSedatives & hypnotics
Sedatives & hypnotics
Dr Resu Neha Reddy
 
Antihistamines
AntihistaminesAntihistamines
Anti adrenergic drugs
Anti adrenergic drugsAnti adrenergic drugs
Anti adrenergic drugs
Shagufta Farooqui
 
cholinergic drugs _abhijit.pptx
cholinergic drugs _abhijit.pptxcholinergic drugs _abhijit.pptx
cholinergic drugs _abhijit.pptx
ABHIJIT BHOYAR
 
OPIOID ANALGESICS
OPIOID ANALGESICSOPIOID ANALGESICS
Anticholinergics
AnticholinergicsAnticholinergics
Anticholinergics
Mesfin Mulugeta
 
Notes sedative & hypnotics
Notes sedative & hypnoticsNotes sedative & hypnotics
Notes sedative & hypnotics
Babitha Devu
 
Adrenergic drugs β adrenergic blocker
Adrenergic drugs β adrenergic blockerAdrenergic drugs β adrenergic blocker
Adrenergic drugs β adrenergic blocker
Subramani Parasuraman
 
Antitussives
Antitussives Antitussives
Antitussives
Sadaqat Ali
 
Beta blockers - pharmacology
Beta blockers - pharmacologyBeta blockers - pharmacology
Beta blockers - pharmacology
PARUL UNIVERSITY
 
Skeletal muscle relaxant
Skeletal muscle relaxantSkeletal muscle relaxant
Skeletal muscle relaxant
Subramani Parasuraman
 
21.drugs used in peptic ulcer
21.drugs used in peptic ulcer21.drugs used in peptic ulcer
21.drugs used in peptic ulcer
Dr.Manish Kumar
 
Anti-Parkinsonism Drugs / Drugs Used in the treatment of Parkinson's Disease
Anti-Parkinsonism Drugs / Drugs Used in the treatment of Parkinson's DiseaseAnti-Parkinsonism Drugs / Drugs Used in the treatment of Parkinson's Disease
Anti-Parkinsonism Drugs / Drugs Used in the treatment of Parkinson's Disease
Kameshwaran Sugavanam
 
general and local anesthesia
general and local anesthesia general and local anesthesia
general and local anesthesia
SONALPANDE5
 
Anti-anxiety drugs
Anti-anxiety drugsAnti-anxiety drugs
Anti-anxiety drugs
Dr Renju Ravi
 

What's hot (20)

Antiadrenergic system and drugs
Antiadrenergic system and drugsAntiadrenergic system and drugs
Antiadrenergic system and drugs
 
CNS stimulants - Parmacology
CNS stimulants - ParmacologyCNS stimulants - Parmacology
CNS stimulants - Parmacology
 
Skeletal muscle relaxants
Skeletal muscle relaxantsSkeletal muscle relaxants
Skeletal muscle relaxants
 
Antiepileptics
AntiepilepticsAntiepileptics
Antiepileptics
 
Anticholinergic drugs
Anticholinergic drugsAnticholinergic drugs
Anticholinergic drugs
 
Sedatives & hypnotics
Sedatives & hypnoticsSedatives & hypnotics
Sedatives & hypnotics
 
Antihistamines
AntihistaminesAntihistamines
Antihistamines
 
Anti adrenergic drugs
Anti adrenergic drugsAnti adrenergic drugs
Anti adrenergic drugs
 
cholinergic drugs _abhijit.pptx
cholinergic drugs _abhijit.pptxcholinergic drugs _abhijit.pptx
cholinergic drugs _abhijit.pptx
 
OPIOID ANALGESICS
OPIOID ANALGESICSOPIOID ANALGESICS
OPIOID ANALGESICS
 
Anticholinergics
AnticholinergicsAnticholinergics
Anticholinergics
 
Notes sedative & hypnotics
Notes sedative & hypnoticsNotes sedative & hypnotics
Notes sedative & hypnotics
 
Adrenergic drugs β adrenergic blocker
Adrenergic drugs β adrenergic blockerAdrenergic drugs β adrenergic blocker
Adrenergic drugs β adrenergic blocker
 
Antitussives
Antitussives Antitussives
Antitussives
 
Beta blockers - pharmacology
Beta blockers - pharmacologyBeta blockers - pharmacology
Beta blockers - pharmacology
 
Skeletal muscle relaxant
Skeletal muscle relaxantSkeletal muscle relaxant
Skeletal muscle relaxant
 
21.drugs used in peptic ulcer
21.drugs used in peptic ulcer21.drugs used in peptic ulcer
21.drugs used in peptic ulcer
 
Anti-Parkinsonism Drugs / Drugs Used in the treatment of Parkinson's Disease
Anti-Parkinsonism Drugs / Drugs Used in the treatment of Parkinson's DiseaseAnti-Parkinsonism Drugs / Drugs Used in the treatment of Parkinson's Disease
Anti-Parkinsonism Drugs / Drugs Used in the treatment of Parkinson's Disease
 
general and local anesthesia
general and local anesthesia general and local anesthesia
general and local anesthesia
 
Anti-anxiety drugs
Anti-anxiety drugsAnti-anxiety drugs
Anti-anxiety drugs
 

Similar to Anticholinergic drugs_abhijit.pptx

Anti cholinergic drugs
Anti cholinergic drugsAnti cholinergic drugs
Anti cholinergic drugs
SabaShaikh76
 
Anticholinergic Drugs
Anticholinergic DrugsAnticholinergic Drugs
Anticholinergic Drugs
Dr. Pramod B
 
Parasympatholytics/ Anticholinergic/ Muscarinic blockers/ Atropine
Parasympatholytics/ Anticholinergic/ Muscarinic blockers/ AtropineParasympatholytics/ Anticholinergic/ Muscarinic blockers/ Atropine
Parasympatholytics/ Anticholinergic/ Muscarinic blockers/ Atropine
mayur kale
 
CHOLINERGIC DRUGS by agen Moses in pharmacology.pptx
CHOLINERGIC DRUGS by agen Moses in pharmacology.pptxCHOLINERGIC DRUGS by agen Moses in pharmacology.pptx
CHOLINERGIC DRUGS by agen Moses in pharmacology.pptx
OcquliVictor
 
Pharmacology of Anticholinergics - drdhriti
Pharmacology of Anticholinergics  - drdhriti Pharmacology of Anticholinergics  - drdhriti
Pharmacology of Anticholinergics - drdhriti
http://neigrihms.gov.in/
 
Cholinergic receptor antagonists presentation
Cholinergic  receptor  antagonists presentationCholinergic  receptor  antagonists presentation
Cholinergic receptor antagonists presentation
sigei meshack
 
AUTONOMIC NERVOUS SYSTEM.pptx
AUTONOMIC NERVOUS SYSTEM.pptxAUTONOMIC NERVOUS SYSTEM.pptx
AUTONOMIC NERVOUS SYSTEM.pptx
HamseHaybe
 
Anticholinergics
AnticholinergicsAnticholinergics
Anticholinergics
Dhanya Palappallil
 
ANTI CHOLINERGIC DRUGS
ANTI CHOLINERGIC DRUGSANTI CHOLINERGIC DRUGS
ANTI CHOLINERGIC DRUGS
Dr. JITENDER BANSI
 
Parasympatholytic drugs
Parasympatholytic drugsParasympatholytic drugs
Parasympatholytic drugs
Shagufta Farooqui
 
Antimuscarinic Agents
Antimuscarinic Agents Antimuscarinic Agents
Antimuscarinic Agents
RABBI
 
Cholinergic agonsit and antagonist as per ER 2020 by Manjushree Gunjegaonkar
Cholinergic agonsit and antagonist as per ER 2020 by Manjushree GunjegaonkarCholinergic agonsit and antagonist as per ER 2020 by Manjushree Gunjegaonkar
Cholinergic agonsit and antagonist as per ER 2020 by Manjushree Gunjegaonkar
Manjushree Gunjegaonkar
 
Psychopharmacology
PsychopharmacologyPsychopharmacology
Psychopharmacology
JishaSrivastava
 
ANTIMUSCARINICS .pptx
ANTIMUSCARINICS .pptxANTIMUSCARINICS .pptx
ANTIMUSCARINICS .pptx
minel5
 
Miotics mydriatics cycloplegics
Miotics mydriatics cycloplegicsMiotics mydriatics cycloplegics
Miotics mydriatics cycloplegics
Chakri Psb
 
cholinergics and anticholinergics presentation.pptx
cholinergics and anticholinergics presentation.pptxcholinergics and anticholinergics presentation.pptx
cholinergics and anticholinergics presentation.pptx
NoorSalam17
 
Anticholinesterase
AnticholinesteraseAnticholinesterase
Anticholinesterase
mehrasa nikandish
 
NonSteroidal Anti-Inflammatory Drugs (NSAIDs)
NonSteroidal Anti-Inflammatory Drugs (NSAIDs)NonSteroidal Anti-Inflammatory Drugs (NSAIDs)
NonSteroidal Anti-Inflammatory Drugs (NSAIDs)
HimanshuJoshi255
 
Anticholinergic drugs
Anticholinergic drugsAnticholinergic drugs
Anticholinergic drugs
Subham Kumar Vishwakarma
 
Cholinergic drugs
Cholinergic drugsCholinergic drugs
Cholinergic drugs
shayanfatima
 

Similar to Anticholinergic drugs_abhijit.pptx (20)

Anti cholinergic drugs
Anti cholinergic drugsAnti cholinergic drugs
Anti cholinergic drugs
 
Anticholinergic Drugs
Anticholinergic DrugsAnticholinergic Drugs
Anticholinergic Drugs
 
Parasympatholytics/ Anticholinergic/ Muscarinic blockers/ Atropine
Parasympatholytics/ Anticholinergic/ Muscarinic blockers/ AtropineParasympatholytics/ Anticholinergic/ Muscarinic blockers/ Atropine
Parasympatholytics/ Anticholinergic/ Muscarinic blockers/ Atropine
 
CHOLINERGIC DRUGS by agen Moses in pharmacology.pptx
CHOLINERGIC DRUGS by agen Moses in pharmacology.pptxCHOLINERGIC DRUGS by agen Moses in pharmacology.pptx
CHOLINERGIC DRUGS by agen Moses in pharmacology.pptx
 
Pharmacology of Anticholinergics - drdhriti
Pharmacology of Anticholinergics  - drdhriti Pharmacology of Anticholinergics  - drdhriti
Pharmacology of Anticholinergics - drdhriti
 
Cholinergic receptor antagonists presentation
Cholinergic  receptor  antagonists presentationCholinergic  receptor  antagonists presentation
Cholinergic receptor antagonists presentation
 
AUTONOMIC NERVOUS SYSTEM.pptx
AUTONOMIC NERVOUS SYSTEM.pptxAUTONOMIC NERVOUS SYSTEM.pptx
AUTONOMIC NERVOUS SYSTEM.pptx
 
Anticholinergics
AnticholinergicsAnticholinergics
Anticholinergics
 
ANTI CHOLINERGIC DRUGS
ANTI CHOLINERGIC DRUGSANTI CHOLINERGIC DRUGS
ANTI CHOLINERGIC DRUGS
 
Parasympatholytic drugs
Parasympatholytic drugsParasympatholytic drugs
Parasympatholytic drugs
 
Antimuscarinic Agents
Antimuscarinic Agents Antimuscarinic Agents
Antimuscarinic Agents
 
Cholinergic agonsit and antagonist as per ER 2020 by Manjushree Gunjegaonkar
Cholinergic agonsit and antagonist as per ER 2020 by Manjushree GunjegaonkarCholinergic agonsit and antagonist as per ER 2020 by Manjushree Gunjegaonkar
Cholinergic agonsit and antagonist as per ER 2020 by Manjushree Gunjegaonkar
 
Psychopharmacology
PsychopharmacologyPsychopharmacology
Psychopharmacology
 
ANTIMUSCARINICS .pptx
ANTIMUSCARINICS .pptxANTIMUSCARINICS .pptx
ANTIMUSCARINICS .pptx
 
Miotics mydriatics cycloplegics
Miotics mydriatics cycloplegicsMiotics mydriatics cycloplegics
Miotics mydriatics cycloplegics
 
cholinergics and anticholinergics presentation.pptx
cholinergics and anticholinergics presentation.pptxcholinergics and anticholinergics presentation.pptx
cholinergics and anticholinergics presentation.pptx
 
Anticholinesterase
AnticholinesteraseAnticholinesterase
Anticholinesterase
 
NonSteroidal Anti-Inflammatory Drugs (NSAIDs)
NonSteroidal Anti-Inflammatory Drugs (NSAIDs)NonSteroidal Anti-Inflammatory Drugs (NSAIDs)
NonSteroidal Anti-Inflammatory Drugs (NSAIDs)
 
Anticholinergic drugs
Anticholinergic drugsAnticholinergic drugs
Anticholinergic drugs
 
Cholinergic drugs
Cholinergic drugsCholinergic drugs
Cholinergic drugs
 

More from ABHIJIT BHOYAR

Group Dynamic(presentation for nursing management)
Group Dynamic(presentation for nursing management)Group Dynamic(presentation for nursing management)
Group Dynamic(presentation for nursing management)
ABHIJIT BHOYAR
 
Discipline. pptx (Nursing management) nursing
Discipline. pptx (Nursing management) nursingDiscipline. pptx (Nursing management) nursing
Discipline. pptx (Nursing management) nursing
ABHIJIT BHOYAR
 
Diagnostic importance of enzymes.pptx
Diagnostic importance of enzymes.pptxDiagnostic importance of enzymes.pptx
Diagnostic importance of enzymes.pptx
ABHIJIT BHOYAR
 
Isoenzyme.pptx
Isoenzyme.pptxIsoenzyme.pptx
Isoenzyme.pptx
ABHIJIT BHOYAR
 
Enzymes.pptx
Enzymes.pptxEnzymes.pptx
Enzymes.pptx
ABHIJIT BHOYAR
 
Atherosclerosis. pptx
Atherosclerosis. pptxAtherosclerosis. pptx
Atherosclerosis. pptx
ABHIJIT BHOYAR
 
Lipoproteins & Lipid Profile .pptx
Lipoproteins & Lipid Profile .pptxLipoproteins & Lipid Profile .pptx
Lipoproteins & Lipid Profile .pptx
ABHIJIT BHOYAR
 
Ketone Bodies.pptx
Ketone Bodies.pptxKetone Bodies.pptx
Ketone Bodies.pptx
ABHIJIT BHOYAR
 
Cholesterol.pptx
Cholesterol.pptxCholesterol.pptx
Cholesterol.pptx
ABHIJIT BHOYAR
 
LIPIDS- Metabolism of Lipids.pptx
LIPIDS- Metabolism of Lipids.pptxLIPIDS- Metabolism of Lipids.pptx
LIPIDS- Metabolism of Lipids.pptx
ABHIJIT BHOYAR
 
LIPIDS-Digestion and absorption of Lipids.pptx
LIPIDS-Digestion and absorption of Lipids.pptxLIPIDS-Digestion and absorption of Lipids.pptx
LIPIDS-Digestion and absorption of Lipids.pptx
ABHIJIT BHOYAR
 
Lipids Classification, Essential.pptx
Lipids Classification, Essential.pptxLipids Classification, Essential.pptx
Lipids Classification, Essential.pptx
ABHIJIT BHOYAR
 
2. LIPIDS (Fatty Acids).pptx
2. LIPIDS (Fatty Acids).pptx2. LIPIDS (Fatty Acids).pptx
2. LIPIDS (Fatty Acids).pptx
ABHIJIT BHOYAR
 
lipids, Def. Classification, Function.pptx
lipids, Def. Classification, Function.pptxlipids, Def. Classification, Function.pptx
lipids, Def. Classification, Function.pptx
ABHIJIT BHOYAR
 
UTERUS_Nursing.pptx
UTERUS_Nursing.pptxUTERUS_Nursing.pptx
UTERUS_Nursing.pptx
ABHIJIT BHOYAR
 
Kidney_Nursing.pptx
Kidney_Nursing.pptxKidney_Nursing.pptx
Kidney_Nursing.pptx
ABHIJIT BHOYAR
 
Liver_Nursing.pptx
Liver_Nursing.pptxLiver_Nursing.pptx
Liver_Nursing.pptx
ABHIJIT BHOYAR
 
Pancreas_Nursing.pptx
Pancreas_Nursing.pptxPancreas_Nursing.pptx
Pancreas_Nursing.pptx
ABHIJIT BHOYAR
 
Spleen.pptx
Spleen.pptxSpleen.pptx
Spleen.pptx
ABHIJIT BHOYAR
 
Popliteal Fossa.pptx
Popliteal Fossa.pptxPopliteal Fossa.pptx
Popliteal Fossa.pptx
ABHIJIT BHOYAR
 

More from ABHIJIT BHOYAR (20)

Group Dynamic(presentation for nursing management)
Group Dynamic(presentation for nursing management)Group Dynamic(presentation for nursing management)
Group Dynamic(presentation for nursing management)
 
Discipline. pptx (Nursing management) nursing
Discipline. pptx (Nursing management) nursingDiscipline. pptx (Nursing management) nursing
Discipline. pptx (Nursing management) nursing
 
Diagnostic importance of enzymes.pptx
Diagnostic importance of enzymes.pptxDiagnostic importance of enzymes.pptx
Diagnostic importance of enzymes.pptx
 
Isoenzyme.pptx
Isoenzyme.pptxIsoenzyme.pptx
Isoenzyme.pptx
 
Enzymes.pptx
Enzymes.pptxEnzymes.pptx
Enzymes.pptx
 
Atherosclerosis. pptx
Atherosclerosis. pptxAtherosclerosis. pptx
Atherosclerosis. pptx
 
Lipoproteins & Lipid Profile .pptx
Lipoproteins & Lipid Profile .pptxLipoproteins & Lipid Profile .pptx
Lipoproteins & Lipid Profile .pptx
 
Ketone Bodies.pptx
Ketone Bodies.pptxKetone Bodies.pptx
Ketone Bodies.pptx
 
Cholesterol.pptx
Cholesterol.pptxCholesterol.pptx
Cholesterol.pptx
 
LIPIDS- Metabolism of Lipids.pptx
LIPIDS- Metabolism of Lipids.pptxLIPIDS- Metabolism of Lipids.pptx
LIPIDS- Metabolism of Lipids.pptx
 
LIPIDS-Digestion and absorption of Lipids.pptx
LIPIDS-Digestion and absorption of Lipids.pptxLIPIDS-Digestion and absorption of Lipids.pptx
LIPIDS-Digestion and absorption of Lipids.pptx
 
Lipids Classification, Essential.pptx
Lipids Classification, Essential.pptxLipids Classification, Essential.pptx
Lipids Classification, Essential.pptx
 
2. LIPIDS (Fatty Acids).pptx
2. LIPIDS (Fatty Acids).pptx2. LIPIDS (Fatty Acids).pptx
2. LIPIDS (Fatty Acids).pptx
 
lipids, Def. Classification, Function.pptx
lipids, Def. Classification, Function.pptxlipids, Def. Classification, Function.pptx
lipids, Def. Classification, Function.pptx
 
UTERUS_Nursing.pptx
UTERUS_Nursing.pptxUTERUS_Nursing.pptx
UTERUS_Nursing.pptx
 
Kidney_Nursing.pptx
Kidney_Nursing.pptxKidney_Nursing.pptx
Kidney_Nursing.pptx
 
Liver_Nursing.pptx
Liver_Nursing.pptxLiver_Nursing.pptx
Liver_Nursing.pptx
 
Pancreas_Nursing.pptx
Pancreas_Nursing.pptxPancreas_Nursing.pptx
Pancreas_Nursing.pptx
 
Spleen.pptx
Spleen.pptxSpleen.pptx
Spleen.pptx
 
Popliteal Fossa.pptx
Popliteal Fossa.pptxPopliteal Fossa.pptx
Popliteal Fossa.pptx
 

Recently uploaded

MATATAG CURRICULUM: ASSESSING THE READINESS OF ELEM. PUBLIC SCHOOL TEACHERS I...
MATATAG CURRICULUM: ASSESSING THE READINESS OF ELEM. PUBLIC SCHOOL TEACHERS I...MATATAG CURRICULUM: ASSESSING THE READINESS OF ELEM. PUBLIC SCHOOL TEACHERS I...
MATATAG CURRICULUM: ASSESSING THE READINESS OF ELEM. PUBLIC SCHOOL TEACHERS I...
NelTorrente
 
Advantages and Disadvantages of CMS from an SEO Perspective
Advantages and Disadvantages of CMS from an SEO PerspectiveAdvantages and Disadvantages of CMS from an SEO Perspective
Advantages and Disadvantages of CMS from an SEO Perspective
Krisztián Száraz
 
RPMS TEMPLATE FOR SCHOOL YEAR 2023-2024 FOR TEACHER 1 TO TEACHER 3
RPMS TEMPLATE FOR SCHOOL YEAR 2023-2024 FOR TEACHER 1 TO TEACHER 3RPMS TEMPLATE FOR SCHOOL YEAR 2023-2024 FOR TEACHER 1 TO TEACHER 3
RPMS TEMPLATE FOR SCHOOL YEAR 2023-2024 FOR TEACHER 1 TO TEACHER 3
IreneSebastianRueco1
 
The Diamonds of 2023-2024 in the IGRA collection
The Diamonds of 2023-2024 in the IGRA collectionThe Diamonds of 2023-2024 in the IGRA collection
The Diamonds of 2023-2024 in the IGRA collection
Israel Genealogy Research Association
 
Azure Interview Questions and Answers PDF By ScholarHat
Azure Interview Questions and Answers PDF By ScholarHatAzure Interview Questions and Answers PDF By ScholarHat
Azure Interview Questions and Answers PDF By ScholarHat
Scholarhat
 
The basics of sentences session 5pptx.pptx
The basics of sentences session 5pptx.pptxThe basics of sentences session 5pptx.pptx
The basics of sentences session 5pptx.pptx
heathfieldcps1
 
Assignment_4_ArianaBusciglio Marvel(1).docx
Assignment_4_ArianaBusciglio Marvel(1).docxAssignment_4_ArianaBusciglio Marvel(1).docx
Assignment_4_ArianaBusciglio Marvel(1).docx
ArianaBusciglio
 
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Thiyagu K
 
Digital Artefact 1 - Tiny Home Environmental Design
Digital Artefact 1 - Tiny Home Environmental DesignDigital Artefact 1 - Tiny Home Environmental Design
Digital Artefact 1 - Tiny Home Environmental Design
amberjdewit93
 
2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...
Sandy Millin
 
PCOS corelations and management through Ayurveda.
PCOS corelations and management through Ayurveda.PCOS corelations and management through Ayurveda.
PCOS corelations and management through Ayurveda.
Dr. Shivangi Singh Parihar
 
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
EugeneSaldivar
 
Natural birth techniques - Mrs.Akanksha Trivedi Rama University
Natural birth techniques - Mrs.Akanksha Trivedi Rama UniversityNatural birth techniques - Mrs.Akanksha Trivedi Rama University
Natural birth techniques - Mrs.Akanksha Trivedi Rama University
Akanksha trivedi rama nursing college kanpur.
 
DRUGS AND ITS classification slide share
DRUGS AND ITS classification slide shareDRUGS AND ITS classification slide share
DRUGS AND ITS classification slide share
taiba qazi
 
Aficamten in HCM (SEQUOIA HCM TRIAL 2024)
Aficamten in HCM (SEQUOIA HCM TRIAL 2024)Aficamten in HCM (SEQUOIA HCM TRIAL 2024)
Aficamten in HCM (SEQUOIA HCM TRIAL 2024)
Ashish Kohli
 
Pride Month Slides 2024 David Douglas School District
Pride Month Slides 2024 David Douglas School DistrictPride Month Slides 2024 David Douglas School District
Pride Month Slides 2024 David Douglas School District
David Douglas School District
 
World environment day ppt For 5 June 2024
World environment day ppt For 5 June 2024World environment day ppt For 5 June 2024
World environment day ppt For 5 June 2024
ak6969907
 
Digital Artifact 2 - Investigating Pavilion Designs
Digital Artifact 2 - Investigating Pavilion DesignsDigital Artifact 2 - Investigating Pavilion Designs
Digital Artifact 2 - Investigating Pavilion Designs
chanes7
 
Digital Artifact 1 - 10VCD Environments Unit
Digital Artifact 1 - 10VCD Environments UnitDigital Artifact 1 - 10VCD Environments Unit
Digital Artifact 1 - 10VCD Environments Unit
chanes7
 
ANATOMY AND BIOMECHANICS OF HIP JOINT.pdf
ANATOMY AND BIOMECHANICS OF HIP JOINT.pdfANATOMY AND BIOMECHANICS OF HIP JOINT.pdf
ANATOMY AND BIOMECHANICS OF HIP JOINT.pdf
Priyankaranawat4
 

Recently uploaded (20)

MATATAG CURRICULUM: ASSESSING THE READINESS OF ELEM. PUBLIC SCHOOL TEACHERS I...
MATATAG CURRICULUM: ASSESSING THE READINESS OF ELEM. PUBLIC SCHOOL TEACHERS I...MATATAG CURRICULUM: ASSESSING THE READINESS OF ELEM. PUBLIC SCHOOL TEACHERS I...
MATATAG CURRICULUM: ASSESSING THE READINESS OF ELEM. PUBLIC SCHOOL TEACHERS I...
 
Advantages and Disadvantages of CMS from an SEO Perspective
Advantages and Disadvantages of CMS from an SEO PerspectiveAdvantages and Disadvantages of CMS from an SEO Perspective
Advantages and Disadvantages of CMS from an SEO Perspective
 
RPMS TEMPLATE FOR SCHOOL YEAR 2023-2024 FOR TEACHER 1 TO TEACHER 3
RPMS TEMPLATE FOR SCHOOL YEAR 2023-2024 FOR TEACHER 1 TO TEACHER 3RPMS TEMPLATE FOR SCHOOL YEAR 2023-2024 FOR TEACHER 1 TO TEACHER 3
RPMS TEMPLATE FOR SCHOOL YEAR 2023-2024 FOR TEACHER 1 TO TEACHER 3
 
The Diamonds of 2023-2024 in the IGRA collection
The Diamonds of 2023-2024 in the IGRA collectionThe Diamonds of 2023-2024 in the IGRA collection
The Diamonds of 2023-2024 in the IGRA collection
 
Azure Interview Questions and Answers PDF By ScholarHat
Azure Interview Questions and Answers PDF By ScholarHatAzure Interview Questions and Answers PDF By ScholarHat
Azure Interview Questions and Answers PDF By ScholarHat
 
The basics of sentences session 5pptx.pptx
The basics of sentences session 5pptx.pptxThe basics of sentences session 5pptx.pptx
The basics of sentences session 5pptx.pptx
 
Assignment_4_ArianaBusciglio Marvel(1).docx
Assignment_4_ArianaBusciglio Marvel(1).docxAssignment_4_ArianaBusciglio Marvel(1).docx
Assignment_4_ArianaBusciglio Marvel(1).docx
 
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
 
Digital Artefact 1 - Tiny Home Environmental Design
Digital Artefact 1 - Tiny Home Environmental DesignDigital Artefact 1 - Tiny Home Environmental Design
Digital Artefact 1 - Tiny Home Environmental Design
 
2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...
 
PCOS corelations and management through Ayurveda.
PCOS corelations and management through Ayurveda.PCOS corelations and management through Ayurveda.
PCOS corelations and management through Ayurveda.
 
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
 
Natural birth techniques - Mrs.Akanksha Trivedi Rama University
Natural birth techniques - Mrs.Akanksha Trivedi Rama UniversityNatural birth techniques - Mrs.Akanksha Trivedi Rama University
Natural birth techniques - Mrs.Akanksha Trivedi Rama University
 
DRUGS AND ITS classification slide share
DRUGS AND ITS classification slide shareDRUGS AND ITS classification slide share
DRUGS AND ITS classification slide share
 
Aficamten in HCM (SEQUOIA HCM TRIAL 2024)
Aficamten in HCM (SEQUOIA HCM TRIAL 2024)Aficamten in HCM (SEQUOIA HCM TRIAL 2024)
Aficamten in HCM (SEQUOIA HCM TRIAL 2024)
 
Pride Month Slides 2024 David Douglas School District
Pride Month Slides 2024 David Douglas School DistrictPride Month Slides 2024 David Douglas School District
Pride Month Slides 2024 David Douglas School District
 
World environment day ppt For 5 June 2024
World environment day ppt For 5 June 2024World environment day ppt For 5 June 2024
World environment day ppt For 5 June 2024
 
Digital Artifact 2 - Investigating Pavilion Designs
Digital Artifact 2 - Investigating Pavilion DesignsDigital Artifact 2 - Investigating Pavilion Designs
Digital Artifact 2 - Investigating Pavilion Designs
 
Digital Artifact 1 - 10VCD Environments Unit
Digital Artifact 1 - 10VCD Environments UnitDigital Artifact 1 - 10VCD Environments Unit
Digital Artifact 1 - 10VCD Environments Unit
 
ANATOMY AND BIOMECHANICS OF HIP JOINT.pdf
ANATOMY AND BIOMECHANICS OF HIP JOINT.pdfANATOMY AND BIOMECHANICS OF HIP JOINT.pdf
ANATOMY AND BIOMECHANICS OF HIP JOINT.pdf
 

Anticholinergic drugs_abhijit.pptx

  • 2. INTRODUCTION • Anticholinergic drugs are agents which block the effects of acetylcholine on cholinergic receptors but conventionally antimuscarinic drugs are referred to as anticholinergic drugs. • They are also called cholinergic blocking or parasympatholytic drugs. • Drugs that block the nicotinic receptors are ganglion blockers and neuromuscular blockers.
  • 3. • Anticholinergic drugs include atropine and related drugs—atropine is the prototype. • Atropine is obtained from the plant Atropa belladonna. Atropine and scopolamine (hyoscine) are the belladonna alkaloids. • They compete with acetylcholine for muscarinic receptors and block these receptors—they are muscarinic antagonists.
  • 5. Actions of anticholinergic drug • The actions of atropine and scopolamine are similar except that atropine is a CNS stimulant while scopolamine is a CNS depressant and causes sedation. 1. CVS—Atropine increases heart rate. In large doses, vasodilation and hypotension occurs.
  • 6. Actions of anticholinergic drug 2. Secretions—Atropine reduces all secretions except milk. Lacrimal, salivary, nasopharyngeal, tracheobronchial and gastric secretions are decreased. • Decreased salivation results in dry mouth and difficulty in swallowing—it is an antisialogogue. Sweating is also reduced
  • 7. Actions of anticholinergic drug 3. Smooth muscle • GIT – ↓ tone and motility and relieves spasm →may result in constipation. • Biliary tract – smooth muscles are relaxed; biliary spasm is relieved. • Bronchi – atropine causes bronchodilatation. • Urinary bladder – relaxes ureter and urinary bladder and may cause urinary retention particularly in the elderly men because they may be having prostatic hypertrophy.
  • 8. Actions of anticholinergic drug 4. Eye—On local instillation, atropine produces mydriasis by blocking the muscarinic receptors in the sphincter pupillae. • The ciliary muscle is paralysed resulting in cycloplegia or paralysis of accommodation. • Because of mydriasis, the iris may block the drainage of aqueous humor—IOP increases and may precipitate glaucoma in some patients.
  • 9. Actions of anticholinergic drug 5. CNS—In higher doses atropine stimulates the CNS resulting in restlessness, disorientation, hallucinations and delirium. In contrast, scopolamine produces sedation and drowsiness.
  • 10. Pharmacokinetics • Atropine and hyoscine are well-absorbed, cross the BBB and are metabolised in the liver.
  • 11. Adverse effects Use of anticholinergic agents may result to these adverse effects: • CNS: blurred vision, pupil dilation, photophobia, cycloplegia, increased intraocular pressure, weakness, dizziness, insomnia • CV: tachycardia, palpitation • GI: dry mouth, altered taste perception, nausea, heartburn, constipation • GU: urinary hesitancy and retention, heat prostration
  • 12. Uses of Belladonna Alkaloids 1. As antispasmodic • In diarrhoea and dysentery, atropine relieves colic and abdominal pain. • In renal and biliary colic—atropine is used with morphine because atropine partly overcomes spasm of the sphincter of Oddi. • Nocturnal enuresis in children and in paraplegia atropine reduces urinary frequency.
  • 13. Use 2. As mydriatric and cycloplegic • Diagnostic for testing error of refraction and fundoscopic examination of the eye. • Therapeutic To provide rest to the iris in iritis, iridocyclitis, keratitis and after partial iridectomy. • Mydriatics are used alternately with miotics to break adhesions between the iris and the lens - both for the treatment and prevention of adhesion formation.
  • 14. Use 3. As pre-anaesthetic medication When administered 30 min before anaesthesia, atropine reduces salivary and respiratory secretions. This will prevent the development of laryngospasm. It also prevents bradycardia during surgery. Its bronchodilator action is of additional value. • Glycopyrrolate an atropine substitute, is most commonly used for this purpose
  • 15. Use 4. In organophosphorus poisoning Atropine is life saving in OP poisoning and is also useful in mushroom poisoning. 5. In bronchial asthma, peptic ulcer and parkinsonism Atropine derivatives are preferred over atropine
  • 16. Use 6. Motion sickness Hyoscine given 30 minutes before the journey prevents travelling sickness. Transdermal hyoscine patches are available to be applied behind the ear for a prolonged action 7. Hyoscine can also be used during labour to produce sedation and amnesia.
  • 17. Drug interactions • When anticholinergics are given with other drugs that also have anticholinergic property like antihistaminics, phenothiazines, tricyclic antidepressants
  • 18. ATROPINE SUBSTITUTES • Belladonna alkaloids produce a wide range of effects, most of which are of therapeutic value. • But these can also result in various side effects since they lack selectivity. • Hence several semisynthetic and synthetic derivatives have been introduced some of which have selective actions
  • 19. • Mydriasis and cycloplegia produced by atropine last for 7–10 days. The derivatives have shorter action (6–24 hrs), tropicamide being the shortest acting. • Some can selectively produce either prominent mydriasis or cycloplegia.
  • 20. • Antispasmodics or spasmolytics are used to relieve spasms of the gastrointestinal tract, biliary tract, ureter and uterus. They are also found to be useful in irritable bowel syndrome. Some of them in addition, reduce gastrointestinal motility.
  • 21. Atropine substitutes Indications Derivatives 1. On the eye – mydriatics and cycloplegics Homatropine, eucatropine, cyclopentolate, tropicamide 2. As antispasmodics Propantheline, methantheline, dicyclomine, flavoxate hydrochloride, oxybutynin chloride, oxyphenonium, glycopyrrolate, clidinium 3. Peptic Ulcer Pirenzepine, telenzepine 4. Bronchial asthma Ipratropium, tiotropium 5. Preanaesthetic medication Glycopyrrolate 6. Urinary disorders Oxybutynin, tolterodine, propiverine, dicyclomine 7. Antiparkinsonian drugs Benzhexol, benztropine, trihexyphenidyl.
  • 22. • Pirenzepine and telenzepine are selective M1 blockers which inhibit gastric secretion at doses that do not affect other functions. • Pirenzepine also does not cross the BBB – hence has no CNS effects. They are tried in peptic ulcer. • When used in bronchial asthma, atropine thickens the bronchial secretions and interferes with the movement of cilia, thus favouring formation of mucus plugs.
  • 23. • Ipratropium bromide is a bronchodilator that does not affect mucociliary activity. • When given as inhalation it acts only on the airways and does not produce any significant systemic effects because it is poorly absorbed.
  • 24. • Glycopyrrolat is an antisialogogue (reduces salivary secretions). It is e a quaternary amine – does not cross the BBB – therefore no effects on the CNS. It is given IM as preanaesthetic medication and in dental practice when it is necessary to reduce salivary secretions. • Benztropine, benzhexol and trihexyphenidyl are the derivatives used in drug induced parkinsonism.
  • 25. • Urinary disorders – atropine substitutes are used to reduce urinary urgency and frequency to relieve bladder spasm and improve bladder capacity in urinary disorders and following urologic surgeries. They are also tried in nocturnal enuresis in children.
  • 26. Contraindications and Cautions The following are contraindications and cautions for the use of anticholinergics: • Allergy to any component of the drug. To prevent hypersensitivity reaction • Glaucoma. Can be exacerbated by blockade of PNS. • Intestinal atony, paralytic ileus, GI obstruction. Can be exacerbated with further slowing of GI activity. • Pregnancy. Potential adverse effects on the fetus.
  • 27. Nursing Considerations Here are important nursing considerations when administering anticholinergics: Nursing Assessment These are the important things the nurse should include in conducting assessment, history taking, and examination: • Assess for contraindications or cautions (e.g., history of allergy to drug, GI obstruction, hepatorenal dysfunction, etc.) to avoid adverse effects. • Establish baseline physical assessment to monitor for any potential adverse effects.
  • 28. • Assess neurological status (e.g., orientation, affect, reflexes) to evaluate any CNS effects. • Assess abdomen (e.g., bowel sounds, bowel and bladder patterns, urinary output) to evaluate for GI and GU adverse effects. • Monitor laboratory test results to determine need for possible dose adjustments and to identify potential toxicity.
  • 29. • Ensure proper administration of the drug to ensure effective use and decrease the risk of adverse effects. • Monitor patient response (e.g., blood pressure, ECG, urine output) for changes that may indicate need to adjust dose. • Provide comfort measures (e.g., sugarless lozenges, lighting control, small and frequent meals) to help patient cope with drug effects. • Provide patient education about drug effects and warning signs to report to enhance knowledge about drug therapy and promote compliance.